Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation.
暂无分享,去创建一个
M Borggrefe | G Breithardt | G. Breithardt | M. Borggrefe | O. Schober | K. Schäfers | T. Wichter | T. Kuwert | T Kuwert | M Schäfers | T Wichter | H Lerch | P Matheja | K Schäfers | O Schober | H. Lerch | M. Schäfers | P. Matheja | Thomas Wichter | G. Breithardt | Martin Borggrefe | M. Schäfers | Torsten Kuwert | O. Schober | T. Wichter | M. Borggrefe
[1] H. Calkins,et al. Scintigraphic Pattern of Regional Cardiac Sympathetic Innervation in Patients With Familial Long QT Syndrome Using Positron Emission Tomography , 1993, Circulation.
[2] G. Breithardt,et al. Catheter ablation of idiopathic right ventricular tachycardia. , 1990, Circulation.
[3] S. Ikeda,et al. Iodine-123-metaiodobenzylguanidine myocardial imaging in patients with right ventricular pressure overload. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] G. Breithardt,et al. Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American College of Cardiology. , 1991, European heart journal.
[5] S. Vatner,et al. Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. , 1993, The Journal of clinical investigation.
[6] S. Amara,et al. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] A. Camm,et al. Asymmetry of cardiac [1231] meta-iodobenzyl-guanidine scans in patients with ventricular tachycardia and a "clinically normal" heart , 2022 .
[8] G. Breithardt,et al. Efficacy of Antiarrhythmic Drugs in Patients With Arrhythmogenic Right Ventricular Disease: Results in Patients With Inducible and Noninducible Ventricular Tachycardia , 1992, Circulation.
[9] E. Kleinhans,et al. Three-Dimensional ROI-Based Quantification of Stress/Rest 201TI Myocardial SPECT: Presentation of Method , 1986, Nuklearmedizin.
[10] M. Kienzle,et al. Effect of direct, reflex and exercise-provoked increases in sympathetic tone on idiopathic ventricular tachycardia. , 1992, The American journal of cardiology.
[11] S. Markowitz,et al. Mechanisms of Idiopathic Left Ventricular Tachycardia , 1997, Journal of cardiovascular electrophysiology.
[12] I. Narabayashi,et al. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy. , 1997, American heart journal.
[13] S. Viskin,et al. Idiopathic Ventricular Tachycardia and Fibrillation , 1993, Journal of cardiovascular electrophysiology.
[14] G. Breithardt,et al. Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. , 1998, Journal of the American College of Cardiology.
[15] G. Breithardt,et al. Regional Myocardial Sympathetic Dysinnervation in Arrhythmogenic Right Ventricular Cardiomyopathy: An Analysis Using 123I‐Meta‐Iodobenzylguanidine Scintigraphy , 1994, Circulation.
[16] S. Viskin,et al. Idiopathic ventricular fibrillation. , 1990, American heart journal.
[17] M. Böhm,et al. Evidence for reduction of norepinephrine uptake sites in the failing human heart. , 1995, Journal of the American College of Cardiology.
[18] D. Battleman,et al. Mechanism of repetitive monomorphic ventricular tachycardia. , 1995, Circulation.
[19] J. Bomanji,et al. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). , 1992, Nuclear medicine communications.
[20] J. Delcán,et al. Idiopathic Ventricular Tachycardia and Fibrillation: Incidence, Prognosis, and Therapy , 1992, Pacing and clinical electrophysiology : PACE.
[21] D. Zipes. Sympathetic stimulation and arrhythmias. , 1991, The New England journal of medicine.
[22] Y. Nakaya,et al. [Idiopathic ventricular fibrillation]. , 1996, Ryoikibetsu shokogun shirizu.
[23] V Hombach,et al. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: a statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. , 1991, Journal of the American College of Cardiology.
[24] C. Reiners,et al. Effect of specific activity on cardiac uptake of iodine-123-MIBG. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] A. Weikl,et al. Congenital Myocardial Sympathetic Dysinnervation (CMSD)—A Structural Defect of Idiopathic Long QT Syndrome , 1991, Pacing and clinical electrophysiology : PACE.
[26] J. Sisson,et al. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] H Kasanuki,et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. , 1997, Circulation.
[28] G. Breithardt,et al. Pathophysiological mechanisms of ventricular tachyarrhythmias. , 1989, European heart journal.
[29] S. Sumita,et al. 123I-MIBG myocardial imaging in hypertensive patients: Abnormality progresses with left ventricular hypertrophy , 1996, Annals of nuclear medicine.